In an age where the volume of data regarding biological systems exceeds our 26 ability to analyse it, many researchers are looking towards systems biology 27 and computational modelling to help unravel the complexities of gene and 28 protein regulatory networks. In particular, the use of discrete modelling allows 29 generation of signalling networks in the absence of full quantitative 30 descriptions of systems, which are necessary for ordinary differential equation 31 (ODE) models. In order to make such techniques more accessible to 32 mainstream researchers, tools such as the BioModelAnalyzer (BMA) have 33 been developed to provide a user-friendly graphical interface for discrete 34 modelling of biological systems. Here we use the BMA to build a library of 35 discrete target functions of known canonical molecular interactions, translated 36 from ordinary differential equations (ODEs). We then show that these BMA 37 target functions can be used to reconstruct complex networks, which can 38 correctly predict many known genetic perturbations. This new library supports 39 the accessibility ethos behind the creation of BMA, providing a toolbox for the 40 construction of complex cell signalling models without the need for extensive 41 experience in computer programming or mathematical modelling, and allows 42 for construction and simulation of complex biological systems with only small 43 amounts of quantitative data. (199 words) 44 45 46 47 48 AUTHOR SUMMARY 50 Ordinary differential equation (ODE) based models are a popular approach for 51 modelling biological networks. A limitation of ODE models is that they require 52 complete networks and detailed kinetic parameterisation. An alternative is the 53 use of discrete, executable models, in which nodes are assigned discrete 54 value ranges, and the relationship between them defined with simple 55 mathematical operations. One tool for constructing such models is the 56
49
INTRODUCTION 79 We are in an era of ever-increasing biological data. With data available from 80 genomic studies, through to metabolomic studies, the size, scale and 81 heterogeneity of the resources available present many triumphs in terms of 82 advancing high-throughput technologies but also many challenges. Despite 83 the enormous multitude of available data, our understanding of how such 84 information encoded in a cell's genome is used to carry out the complex 85 biological interactions found between genes and gene products is still lacking. 86
It is therefore no surprise that a central goal of modern biology in this post-87 genomic era is to understand the structural and temporal nature of these 88 control networks. Not only would this allow us to translate 'Big Data' into 89 working models of biological systems, but also equip us with a better 90 understanding of biological mechanisms, allowing the exploration of emergent 91 behaviours and consequences of genomic variants, with an aim to develop 92 real-world hypotheses for experimental validation. 93 7 negating the need for extensive experience in computer programming, logical 150 formalisms or mathematical proofs [15] . As a result, the BMA is a highly 151 accessible, unimposing interface that is suitable for experimental biologists, 152 whilst still providing powerful stability checking, simulation and Linear 153
Temporal Logic analysis abilities. Although on the surface BMA may appear to 154 be highly abstract, elaborate biological functions can be robustly modelled 155 such as that of C. elegans germline development [16] , mammalian epidermis 156 differentiation [7], gene and protein regulatory networks in chronic myeloid 157 leukaemia (CML) [17] and acute myeloid leukaemia (AML) [18] . In the case of 158 CML, a novel therapeutic strategy using an Imatinib and pan-Bcl2 family gene 159 inhibitor combination has been identified, highlighting BMAs ability to work on 160 either a hypothesis-creation or hypothesis-testing basis. Cell line specific 161 differences in the PIM pathway were identified in the case of AML, leading to 162 clinically relevant predictions about resistance and how to overcome it. 163
164
Although BMA provides the ability to encode complex dependencies between 165 different genes or proteins via the use of algebraic target functions, this task 166 can still seem quite onerous to many biologists. In 2003, Tyson, Chen and 167 Novak [19] published a review outlining a concise mathematical vocabulary of 168 common cellular interactions and pathways using ODEs. In their article, they 169 identify a number of simple functional motifs, akin to electrical circuits which 170 are found at the base of a variety of key biological processes and can be 171 easily combined in order to model complex regulatory interactions. Here we 172 outline a target function library which translates the ODEs outlined by Tyson 173 et al. [19] into discrete equations encoded within nodes of a BMA model. In 8 order to investigate whether these target functions are capable of modelling 175 cellular behaviours of greater complexity, we then created a BMA model of 176 eukaryotic cell cycle regulation similar to Tyson et al [19] . In silico over-177 expression and knockouts of combinations of genes and genetic interactions 178 were then carried out to highlight the sensitivity of our model. A key benefit of 179 using discrete, executable modelling is that complex systems can be 180 simulated and analysed, and experimentally testable hypotheses can be 181 generated in the absence of large amounts of quantitative data required for 182 ODE models. 183 184 This library of ODE translations to discrete target functions also complements 185 the accessibility ethos behind the creation of the BMA. By providing simple 186 building blocks that can be "plugged" into a set of specific nodes, much time 187 and effort will be saved allowing biologists to construct elaborated valid 188 models of biological phenomena, which can guide and direct hypotheses and 189 carried out in the BMA. For all cases bar (d-iv) and (g-iv) the signal is altered 238 from 0 through to 4 directly within the S node and the output in node R 239 recorded and subsequently plotted. For cases (d-iv) and (g-iv) a simulation is 240 run with a set signal input of 4 as an example, and the response output from 241 the BMA simulation plotted based on the response per calculation time step. 242
Graphs plotted from the BMA model (iv) can then be compared to ODE 243 counterpart (iii). In (e-iv) and (f-iv) the dashed line represents an unsteady 244 state. In (e-iv) S crit , which is denoted x in our target function (Supplementary 245 table 1) represents the signal input where a switch in steady states will occur. 246
The motifs in each case reproduce the bifurcation as expected. Similarly, in (f-1 1 iv) S crit1 which is denoted y in our target function and S crit2 which is denoted z 248 in our target function also correspond to the switch points in stable states. 249 250
Hyperbolic Response 251
We generated four ways to discretely model different hyperbolic functions 252 within the BMA. This function describes a "phosphorylation and 253 dephosphorylation" reaction and is modelled using a three-node wiring 254 diagram shown in Fig 1, B, 
Perfect Adaptation Response 281
Adaptation is defined as "a process where a system initially responds to a 282 stimulus, but then returns to basal or near-basal levels of activity after some 283 
Where ‫ݔ‬ represents the maximal height of the response before the system 293 adapts. 294 295
Mutual Activation Response 296
Mutual activation behaviour represents irreversible cell switches, i.e. a "point-297 of-no-return". These discontinuous, one-way switches are typical of cell fate 298 determination. Once a critical signal value (S crit ) is reached, the response 299 immediately increases to a high level. A critical feature of mutual activation 300 networks is that the switch is irreversible i.e. if the signal increases beyond 301 S crit and subsequently decreases, the response will not decrease. Network 302 schematics for mutual activation systems are shown in Fig 1, E, 
Essentially, this works similarly to mutual activation, except if S is decreased 317 below Scrit2 then the switch will return to the inactive state. Our model is 318 composed of 6 nodes and is compared to the "traditional" toggle switch 319 schematic in Fig 1, F, is adjusted such that it is double the range of the other nodes within the 343 system. This is required for stability of the system, as nodes can only alter by 344 a single integer value each time step, a node of granularity 10 (0-9) will take 345 twice as long to reach a maximal value from 0 as a node with a granularity of 346 these networks, an input of S will result in an oscillation that tends to between 365 S and 0. The temporal constraints of the network however (in that each node 366 can only update by a single integer value each step) results in cases where 367 the oscillation will not reach the maximal value before the inhibitory portion of 368 the network kicks in. The ultimate range of the oscillations can be tailored 369 however, with either the addition of values to the output node (in order to 370 adjust the oscillation range up or down), or by inserting the following formula 371 into node A: 372
Where the difference between The activator-inhibitor oscillation relationship is characterised by a positive 400 and negative feedback loop within a system (shown in Fig 2, B, i 
and ii). The 401
interactions of the two loops result in a system that oscillates between a 402 maximal and minimal value, called a hysteresis oscillator. Including the 403 following formula in node A results in an oscillation between the maximal and 404 minimal values of the nodes when I = 2: the following target function is applied to Node A: 422 BMA target function library (Fig 3, A) . Clear descriptions of the dynamics of 437 cell cycle regulation can be found in the following review articles: Tyson, 438 Tyson & Novak (2015) [20] and 439
Hochegger, Takeda & Hunt (2008) [26] . 440 [20] . 466 467 468
G1/S Module 469
The G1/S module features mutual inhibition between Cdk1-cycB and CKI. 470 This feedback loop is described as a "toggle switch" and is modelled using our 471 BMA mutual inhibition target function. Here we model CKI as being present at 472 high levels in G1 by assigning it an initial value of 10 (max based on our 473 granularity choice). The input in this case is labelled as cyclin, which, as it 474 increases causes an increase in bound_Cdk1 (i.e. heterodimer of CKI, Cdk1 & 475 cycB) due to the initial high levels of CKI. As the CKI doesn't stop cyclin 476 accumulation and binding to Cdk molecules, the rising Cdk1-cycB levels 477 1 which are not opposed by CKIs soon tips the balance, phosphorylating the 478 CKI and labelling them for degradation. The values chosen for the switch 479 points can be found in Supplementary table 2 
. 480
Following the degradation of CKI and subsequent spike in Cdk1-cycB activity 483 the cycle enters the G2/M module. This module features both mutual 484 activation, between Cdk1-cycB and Cdc25, and mutual inhibition between 485
Cdk1-cycB and Wee1 [19] . The later works in a similar way to that of Ck1-486 cycB and CKI, with a race occurring being between Cdk1-cycB and Wee1. 487
The Cdk-cycB and Cdc25 mutual activation interaction on the other hand is a 488 type of positive feedback loop, where Cdc25 and Cdk1-cycB activate each 489 other rather than inhibit each other. This is modelled using our BMA mutual 490 inhibition target function combined with the mutual activation target function. 491
Here we model Wee1 as being present at high levels in G2/M by assigning it 492 an initial value of 10. The input in this case comes from the G1_Cdk1 levels, 493 which as it increases causes an increase in phos_Cdk1 (i.e. phosphorylated 494 form of Cdk1-cycB) due to the initial high levels of Wee1. As Wee1 does not 495 stop cyclin accumulation and binding to Cdk molecules, the rising Cdk1-cycB 496 levels (which are not opposed by Wee1) soon tips the balance, 497
phosphorylating the Wee1 and marking them as inactive. Inactive Wee1 498 maintains active Cdc25, thus decreasing Wee1 results in an increase in Once the Cdk1-cycB reaches a high level due to Cdc25 activation the cell 504 enters mitosis. In order to exit this phase, the Cdk1-cycB activity must be 505 destroyed and CKI levels stockpiled. This transition is aided by the 506 Cdc20:APC complex, which itself is indirectly activated by Cdk1-cycB activity, 507 causing degradation of CycB. This results in a substantial drop in Cdk1-cycB 508 activity, which then allows CKI to rise again. This relationship is described as 509 an oscillator based on a negative feedback loop, where Cdk1-cycB activates 510 APC, which activates Cdc20, which then degrades CycB [19] . In the BMA, 511 the negative feedback oscillators target function uses the default function. 512
Therefore this was modelled simply by considering the whole cycle as a 513 feedback loop by adding an inhibitory edge back to the cyclin B in order to 514 create the desired response (Supplementary table 2 & 3) . 515 516
Comparison to ODE Eukaryotic Cell Cycle Model Predictions 517 518
The initial conditions were set so that all nodes remained with an initial value 519 of 0, except for CKI and Wee1 which are given an initial value of 10 (max 520 based on our granularity choice). As Growth, Replicated_DNA, 521
Undamaged_DNA and Aligned_Chromosomes are conditions that can be 522
represented by a binary value, a value of 0 represents the absence of the cell 523 phenotype, whereas a value of 1 corresponds to the presence of the 524 phenotype. The initial values for all four of these phenotypes were therefore 525 set to 1 to represent normal growth conditions. Simulation analysis, starting 526 from this initial state leads to the initiation of a series of network states 527 to the biological time series of protein activation and inactivation that occur 529 during the wild-type cell cycle (Fig 3, B) Fig 3, B shows the cell 532 progresses through the cycle via a number of steady states. Firstly, at low 533 levels of Cdk1-cycB activity the cell will remain in G1. With increased growth it 534 will eventually pass a critical point, resulting in the irreversible disappearance 535 of G1. As the cell moves into the S phase the level of Cdk1-cycB continues to 536 grow until it reaches an intermediate level (3 as determined by our target 537 function). Here in the G2 phase the cell will continue to grow until it reaches 538 the next critical threshold, where the G2 state will disappear. This gives rise to 539 a large spike in Cdk1-cycB activity (driving the cell into mitosis) which then 540 decreases as cycB is degraded by APC:Cdc20, signalling cell division and 541
resetting the system for the next round of division. One added benefit of this 542 model is its ability to continuously cycle, as highlighted in Fig 3, B . (Table 1) . In our limited subset of mutant 550 experiments 8 out of 9 cases were able to accurately replicate the 551 experimental results found in the literature without making any modifications 2 4 to the underlying model described above beyond modelling the mutations (Fig  553   4) . For instance in the case of Cdc25 OP, studies in both yeast and mice have 554
shown that over-production of Cdc25 result in premature entry into mitosis 555 due to early activation of Cdk1-cycB [28, 29] . In the in silico experiment, the 556 same result can be discerned. Rather than needing 8 steps to pass through 557 G2 the Cdc25 OP, the model only takes one step. Similarly less time is spent 558 in M phase with only 1 step occurring versus 2 steps for wild types (WT). This 559 results in the mutant model undergoing each cycle in fewer calculation steps, 560 needing only 33 steps compared to the 41 needed in the WT model. 561
Descriptions of the other seven successfully reproduced experiments can be 562 found in Nurse [30] showed that overexpression of Rum1, a fission yeast CKI, leads to 565 delays in G1, with repeated S-phase and no M-phase. This is partially 566 replicated in our mutant model, with there being a long delay in G1 phase (23 567 calculation steps compared to 14 in the WT model), as well as no M phase 568 being reached (where Cdk1-cycB hits max value of 10). The model however 569 still runs through the M/G1 phase rather than just repeating the S phase. 570 571 We present a library of novel Qualitative Network modules that can accurately 594 replicate the biological behaviour of core, ubiquitous network motifs. We 595 generate and compare our library based on biological behaviours defined 596 previously [19] , and confirm the modular nature of the library with the 597 generation of a model for the eukaryotic cell cycle produced using motifs from 598 the library. By simulating known genetic perturbations we further test this 599 novel qualitative eukaryotic cell cycle model, highlighting its capacity to 600 accurately replicate many well-known mutant phenotypes without the need for 601 explicit parameterisation, as would generally be needed for ODE models. This 602 study constitutes both a toolbox for biologists to construct elaborate networks 603 with ease, but also an example of its application to a relevant biological 604 system. The QN presented has much wider applications, with our working 605 model having the potential to be adapted in order to provide much more 606 dynamic details on the regulation of these core cell cycle components. Such 607 a model could then be utilised to provide new insights into cell cycle regulation 608 allowing the prediction of novel mutant phenotypes that have not been 609 previously investigated. Not only could this provide a more thorough 610 understanding of the underlying cell cycle regulatory principles, but also assist 2 7
in the identification of a host of mutants that contribute to cancers or other 612 pathologies, potentially allowing for the generation of novel drug therapeutics 613 accurately with experimental data, with CKI OP mutants being in partial 662 agreement. This partial agreement is likely due to the minimalistic nature of 663 our model, and could likely be overcome by using additional nodes to model 664 the CKI interaction in more detail. Overall, the model produced using the BMA 665 target function library accurately represents not only the WT regulation 666 patterns of the general cell cycle control engine, but also the dynamic 667 changes resulting from a number of mutants. This showcases our BMA target 668 function library's ability to be easily manipulated in order to model complex 669 networks. Of particular note is the ability of the method to accurately generate 670 protein behaviour through the simple addition of target functions from different 671 modules that act on the same proteins, as is the case with the Cdk1-CycB 672 node in our QN. This ability to draw together simple motifs to create realistic 673 and useful biological networks demonstrates the validity of the approach and 674 the opportunities that executable modelling makes available. 
Qualitative Networks 691
Qualitative networks (QNs) are an extension of Boolean models. In Boolean 693
Networks, nodes are able to be in either and active (1), or inactive state (0), 694
and are connected via functions that describe the mathematical relationship 695 between them in an abstract way. Boolean Networks can be synchronous or 696 asynchronous, that is -they may update every node simultaneously when a 697 change is introduced in the system, or they can update in sequence from a 698 propagation point. Qualitative networks are analogous to a synchronous 699
Boolean Network, except that nodes are able to vary over a wide range of 700 discrete values (called a granularity). Simple networks may be represented as 701
Boolean, but Qualitative Networks may involve nodes with a greater range of 702 values. For example, a node may have a range of 0-2 (granularity 3), where a 703 value of 1 represents "normal activity" of an enzyme or gene product, and 0 704 and 2 represent low and high values respectively. This can be extended for 705 much larger granularities, for example 0-10, where 10 represents maximal 706 activity, and 0 represents minimal activity, with each discrete value in between 707 representing a different concentration. The BMA is an accessible, publicly available (www.biomodelanalyzer.org) 728 graphical tool for discrete modelling and analysis of Qualitative Networks. The 729 platform, with its user-friendly graphical interface, uses visual notations 730 familiar to specialists in biology. BMA models are constructed on a gridded 731 canvas upon which one or more cells, and cell elements (i.e. membrane 732 receptor, cellular proteins etc.) can be placed and connected together with 733 activatory or inhibitory links. To create a model, the user starts by dragging 734 role in the analysis, being purely a visual aid to assist model design clarity. 736
Cell elements are then placed in or outside of these cells, which can represent 737 internal proteins, external proteins or membrane bound receptors. 738
Connections between these cell elements can then be made using activatory 739 arrows or inhibitory bar-arrows. Each cell element can then be labelled 740 accordingly, using the simple drop down menus and a finite value range 741 assigned, with the BMA default being [0,1], or Boolean. This range may be 742 altered to add different levels of concentration, for example a range of [0,2] 743 may represent "low", "normal" and "high" concentrations of a protein or gene. 744
If the user does not specify a target function for a node, then the BMA assigns 745 a default target function. The default target function assigned within the BMA 746 is described as: 747
More complex target functions can be inserted for each node manually using 750 an autocomplete function simplifying the use of correct syntax when 751 referencing variables or using operators. Importing any file into the BMA will load the model and allow manipulation and 1032 simulation/stability analysis. Each file is named explicitly in Supplementary 1033 Table 1 , with some files containing multiple models, which are referenced 1034 independently. 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 Wild Type 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 3 3 3 3 3 3 3 4 5 6 7 8 9 10 10 9 8 7 6 5 4 3 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 3 3 Wee1Δ 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 4 5 6 7 8 9 10 10 9 8 7 6 5 4 3 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 4 5 6 7 8 9 10 10 9 Wee1 OP 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 CKI Δ 0 0 0 0 1 2 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 4 5 6 7 8 9 10 10 9 8 7 6 5 4 3 2 1 0 0 0 0 0 0 0 1 2 3 3 3 3 3 3 3 3 3 3 3 3 CKI OP 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 4 5 6 7 8 7 6 5 4 3 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CKI & Wee1Δ 0 0 0 0 1 2 3 3 3 3 3 3 3 4 5 6 7 8 9 10 10 9 8 7 6 5 4 3 2 1 0 0 0 0 0 0 0 1 2 3 3 3 3 3 3 3 4 5 6 7 8 9 10 10 9 8 7 6 5 4 3 Cdc25 Δ 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 Cdc25 & Wee1Δ 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3
Cdc25 OP 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 4 5 6 7 8 9 10 9 8 7 6 5 4 3 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 4 5 6 7 8 9 10 9 8 7 6 Cdc20 Δ 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 3 3 3 3 3 3 3 4 5 6 7 8 9 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 Damaged DNA 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 Misaligned Chromosomes 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 3 3 3 3 3 3 3 3 4 5 6 7 8 9 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 Key: 
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